Rheumatoid arthritis is a heterogeneous and progressive autoimmune disease, and patients with this condition show varied responses to treatment. Practical, reliable, individually tailored measures ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Higher low-carbohydrate diet (LCD) scores, characterized by reduced carbohydrate intake and increased protein consumption, are associated with a lower likelihood of rheumatoid arthritis (RA) among ...

Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

Kashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary ...

The use of Jusvinza in patients with rheumatoid arthritis with moderate to severe activity left positive experiences in ...

Indian scientists have developed a groundbreaking self-actuating drug delivery system for Rheumatoid Arthritis offering targeted relief with fewer side effects and longer-lasting results ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

Researchers found that genetically predicted rheumatoid arthritis was associated with an increased risk for prostate cancer. HealthDay News — Genetically predicted rheumatoid arthritis (RA) is ...